BIOMAT Database Logo BIOMAT Database Logo

Lack of effect of probucol on serum lipoprotein(a) levels. 1989

S Maeda, and M Okuno, and A Abe, and A Noma

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011341 Probucol A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). Biphenabid,DH-581,Lorelco,Lurselle,Panavir,Superlipid,DH 581,DH581
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA

Related Publications

S Maeda, and M Okuno, and A Abe, and A Noma
Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice.
October 1981, Atherosclerosis,
S Maeda, and M Okuno, and A Abe, and A Noma
Effect of probucol on serum lipoprotein and apoprotein profiles in renal transplant patients.
February 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation,
S Maeda, and M Okuno, and A Abe, and A Noma
[Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
January 1985, Kardiologia polska,
S Maeda, and M Okuno, and A Abe, and A Noma
Lack of effect of erythromycin on theophylline serum levels.
August 1980, Chest,
S Maeda, and M Okuno, and A Abe, and A Noma
[Effect of weight reduction on lipids and lipoprotein (a) serum levels].
November 2002, Medicina clinica,
S Maeda, and M Okuno, and A Abe, and A Noma
Lack of effect of tricyclic antidepressants on serum prolactin levels.
January 1977, Psychopharmacology,
S Maeda, and M Okuno, and A Abe, and A Noma
Lack of effect of a high fat intake on serum lipid levels.
January 1955, The American journal of clinical nutrition,
S Maeda, and M Okuno, and A Abe, and A Noma
The long-term effects of probucol on serum lipid levels.
October 1981, Archives of internal medicine,
S Maeda, and M Okuno, and A Abe, and A Noma
Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
January 1986, Atherosclerosis,
S Maeda, and M Okuno, and A Abe, and A Noma
Lipoprotein oxidation and cytotoxicity: effect of probucol on streptozotocin-treated rats.
July 1988, The American journal of cardiology,
Copied contents to your clipboard!